Merck & Co., Inc. is 27.0x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($293.16 B vs $10.86 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BMRN | MRK |
|---|---|---|
| Market cap | $10.86 B | $293.16 B |
| US-listed rank | #899 | #44 |
| Revenue (latest FY) | $3.22B | $65.01B |
| Net income (latest FY) | $348.90M | $18.25B |
| Net margin | 10.8% | 28.1% |
| P/E (trailing FY) | 31.1 | 16.1 |
| SEC filings | 2,709 | 996 |
Merck & Co., Inc. is 27.0x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($293.16 B vs $10.86 B).
In their latest fiscal years, BIOMARIN PHARMACEUTICAL INC reported $3.22B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: BIOMARIN PHARMACEUTICAL INC and Merck & Co., Inc., or browse the full rankings.